The METEX study: Methotrexate versus expectant management in women with ectopic pregnancy: A randomised controlled trial

• Main Authors: Visser Harry (Author), Verhoeve Harold R (Author), van Santbrink Evert JP (Author), Lips Jos P (Author), Leeuw-Harmsen Loes (Author), Friederich Jaap (Author), Emanuel Mark (Author), Doornbos Johannes PR (Author), Dijkman Antonius B (Author), Boss Erik A (Author), Adriaanse Albert H (Author), Mol Femke (Author), van Mello Norah M (Author), Ankum Willem M (Author), Veen Fulco (Author), Mol Ben W (Author), Hajenius Petra J (Author)
• Format: Book
• Published: BMC, 2008-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Patients with ectopic pregnancy (EP) and low serum hCG concentrations and women with a pregnancy of unknown location (PUL) and plateauing serum hCG levels are commonly treated with systemic methotrexate (MTX). However, there is no ev...